1 Small-Cap Biotech Stock to Buy and Hold For the Next 10 Years
Small cap biotech stocks have a lot of inherent risk, but if you can snag a winner your returns could double many times over. Here's one small-cap biotech stock you can consider buying and holding for the next 10 years.
5 Promising Biotech Stocks Under $10
Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.
Why ImmunoGen Inc. is Skyrocketing Today
ImmunoGen Inc. has sold royalty rights in Kadcyla to TPG Special Situations Partners.